Ascentage Pharma Outlined Its Global Innovation Strategy During Presentation At 44Th Annual J.P. Morgan Healthcare Conference. <li /> Two commercialized hematology products, Olverembatinib and ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback